Vaccines targeting the coronavirus strain that spread in early 2020 and their effectiveness against infection has dropped markedly as new mutants came along, particularly the super-contagious omicron family. Pfizer seeks approval of updated COVID vaccine booster against new variants Pfizer asked U.S. regulators Monday to authorize its combination COVID-19 vaccine that adds protection against the newest omicron relatives — a key step toward opening a fall booster campaign. The Food and Drug Administration ordered vaccine makers to tweak their shots to target BA.4 and BA.5 that are better than ever…
Read MoreTag: FDA
US FDA authorises emergency use for Novavax COVID vaccine for ages 12 to 17
Food and Drug Administration (FDA) of the US has recently approved the COVID-19 vaccine by the biotechnology company ‘Novavax’ for emergency use in teenagers Biotechnology company Novavax announced on Friday that its Covid-19 vaccine has been authorized for emergency use by the U.S Food and Drug Administration for adolescents between the ages of 12 and 17. In July, Novavax’s two-dose Covid-19 vaccine for adults ages 18 and over got its emergency approval from the FDA. Having more vaccine options for adults and children will “hopefully help increase vaccination rates, particularly…
Read More